Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Abbott Unveils Breakup, Plans To Settle Alleged Marketing Misdeeds

Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.

It's a big deal, and Forbes' Matt Herper explains the logic behind it: Investors aren't giving drugmakers much respect, so separating the businesses could give a lift to the future stock of the faster-growing non-drug business.

But there's some other darker news on the drug front that got overshadowed by the company's restructuring. Abbott said it's putting aside $1.5 billion to cover an expected settlement with the federal government of claims that the company went way too far in selling the seizure drug Depakote.

Some former Abbott employees filed a lawsuit, later joined by the feds, that alleges the company promoted Depakote for unapproved uses, such as treatment of Alzheimer's dementia, and that it paid kickbacks to doctors to boost sales.

In a release on company earnings, Abbott disclosed the potential settlement, saying that company expenses now include "$1.5 billion of litigation reserves" related to ongoing settlement discussions related to Depakote.

In an August filing Abbott said:

The United States Department of Justice, through the United States Attorney for the Western District of Virginia, is investigating Abbott's sales and marketing activities for Depakote. The government is seeking to determine whether any of these activities violated civil and/or criminal laws, including the Federal False Claims Act, the Food and Drug Cosmetic Act, and the anti-Kickback Statute in connection with Medicare and/or Medicaid reimbursement to third parties. Discussions are ongoing in an effort to resolve potential civil and criminal claims arising from this matter. Abbott is unable to predict the outcome of this matter or to estimate the range or amount of possible loss and no loss reserves have been recorded for this exposure.

Copyright 2011 National Public Radio. To see more, visit http://www.npr.org/.

NPR

For Alan Cumming, Life Is (Once Again) A Cabaret

This is the third time Cumming has starred in the musical. He talks about the new production — everything from his costume (which he calls a "Wonder Bra" for men) to the darker themes of the show.
NPR

The 3-Bird Turducken Has Nothing On This 17-Bird Royal Roast

The Frenchman who was the world's first restaurant critic launched the world's first serial food journal in 1803. To wow readers, he offered a recipe for for rôti sans pareil, the roast without equal.
NPR

Speaker Boehner Says The House Will Act On Immigration

Republican Rep. John Boehner delivered a statement Friday in reaction to President Obama's immigration address, saying Obama is damaging the presidency.
NPR

Still Reeling From Supreme Court Ruling, Aereo Files For Bankruptcy

The streaming company's founder said fallout from the court's decision in favor of TV networks proved "too difficult to overcome."

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.